Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Towards a Purely Oncogenetic Risk Classification of Adult T-ALL: a GRAALL Study

Blood (2012) 120 (21): 881.

https://doi.org/10.1182/blood.V120.21.881.881

Published: 2012

Journal Articles

Minimal Residual Disease At 3 Months, Combined to the Presence of IKZF1 Deletion in B-Lineage or Absence of NOTCH1 pathway Mutation in T-Lineage, Recapitulates the Disease Risk Assessment in Adults with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia - A GRAALL Study

Blood (2011) 118 (21): 572.

https://doi.org/10.1182/blood.V118.21.572.572

Published: 2011

Journal Articles

Clinical Phenotype and Response to Imatinib of Chronic Myelogenous Leukemia Patients Harbouring Atypical BCR-ABL Transcripts. A Retrospective Analysis From the French Group of CML (Fi-LMC) and the French Group of Molecular Biologists for Hematological Malignancies (GBMHM).

Benedicte Deau, MD, Mathias Montveneur, MStud, Valérie Coiteux, MD, Aline Renneville, MD, Francoise Rigal-Huguet, MD, Eric Delabesse, MD, PhD, Michel Tulliez, MD, Dominique Bories, MD, PhD, Aude Charbonnier, MD, PhD, Marie-Joelle Mozziconacci, MD, PhD, Thibault Legay, MD, Eric Lippert, PhD, Francois-Xavier Mahon, MD, PhD, Delphine Rea, MD, PhD, Jean-Michel Cayuela, PhD, Shanti Amé, MD, Marie-Pierre Gaub, MD, Martine Gardembas, MD, Odile Blanchet, MD, Bruno Audhuy, MD, Agnès Buzyn, MD, PhD, Elisabeth Mac Intyre, MD, PhD, Anna-Lisa Andreoli, MD, Oumedaly Reman, Nathalie Contentin, MD, Christian Bastard, MD, Jean-Christophe Ianotto, MD, Valérie Ugo, MD, PhD, Jean-Jacques Kiladjian, MD, PhD, Said Brahimi, MD, Viviane Dubruille, Jean-Francois Brantus, MD, Mohamad Sobh, Pharm., M., Stephane Morisset, Stat., Claude Preudhomme, MD, PhD, Sandrine Hayette, PhD, Franck E Nicolini, MD, PhD

Blood (2010) 116 (21): 3378.

https://doi.org/10.1182/blood.V116.21.3378.3378

Published: 2010

Journal Articles

Fludarabine Plus Cyclophosphamide and Rituximab In Waldenström's Macroglobulinemia: Results In 55 Patients

Véronique Leblond, Laetitia Compain, Vincent Levy, MD, PhD, Jérôme Tamburini, MD, PhD, Alain Delmer, MD, Jacques Vargaftig, MD, Brigitte Pégourié-Bandelier, MD, Beatrice Mahe, MD, Steven Le Guill, MD, PhD, Olivier Tournilhac, MD, PhD, Elisabeth Brottier-Mancini, MD, Richard Delarue, MD, Agnès Buzyn, MD, PhD, Michel Maigre, MD, Claude Gardin, MD, Sylvain Choquet, MD

Blood (2010) 116 (21): 1757.

https://doi.org/10.1182/blood.V116.21.1757.1757

Published: 2010

Journal Articles

Is There Still a Place for Total Body Irradiation (TBI) In the Conditioning Regimen of Autologous Stem Cell Transplantation In Mantle Cell Lymphoma ?: a Retrospective Study From the Lymphoma Working Party of the EBMT

Blood (2010) 116 (21): 688.

https://doi.org/10.1182/blood.V116.21.688.688

Published: 2010

Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) for Isolated and Leukemic Myeloid Sarcoma (GS): a Survey on Behalf of the Acute Leukemia Working Party (ALWP) of EBMT.

Patrice Chevallier, MD, Myriam Labopin, MD, Jan J. Cornelissen, MD, PhD, Gérard Socié, Per T. Ljungman, MD, PhD, Bruno Lioure, Herve Tilly, MD, Alois Gratwohl, MD, Noel Milpied, MD, Ibrahim Yakoub-Agha, MD, PhD, Liisa Volin, Jean-Paul Vernant, Jacques-Olivier Bay, MD, PhD, Mauricette Michallet, Agnès Buzyn, MD, PhD, Benedicte Samey, Mohamad Mohty, Vanderson Rocha

Blood (2010) 116 (21): 4558.

https://doi.org/10.1182/blood.V116.21.4558.4558

Published: 2010

Journal Articles

Improved Survival for 149 First-Line Multiple Myeloma (MM) Patients (pts) Treated by Tandem Autologous (Auto)/Allogeneic (Allo) Stem Cell Transplantation (SCT) : Retrospective Study of the Société Française de Greffe de Moelle Thérapie Cellulaire (SFGM-TC).

Claire Fabre, Serge Koscielny, Jean-Luc Harousseau, Mohamad Mohty, Didier Blaise, Noël Milpied, Bernard Rio, Mauricette Michallet, Thierry Facon, Jean-Paul Vernant, Agnès Buzyn, Gérard Socié, Jean-Yves Cahn, Natacha Maillard, Jacques-Olivier Bay, Jean-Henri Bourhis

Blood (2009) 114 (22): 1188.

https://doi.org/10.1182/blood.V114.22.1188.1188

Published: 2009

Journal Articles

Impact of Donor-Derived Invariant Natural Killer T (iNKT) Cell Reconstitution After Allogeneic Haematopoietic Stem Cell Transplantation.

Marie T Rubio, Lucia Teixeira, Pierre Milpied, Emmanuel Bachy, Felipe Suarez, David Ghez, Richard Delarue, Agnès Buzyn, Sophie Caillat-Zucman, Bruno Varet, Olivier Hermine, Maria Leite de Moraes

Blood (2009) 114 (22): 346.

https://doi.org/10.1182/blood.V114.22.346.346

Published: 2009

Journal Articles

Prognostic Significance of Complement System Activation After Allogeneic Hematopoietic Stem Cell Transplantation.

Marie T Rubio, Marie A Durey-Dragon, Yi Wang, Jacques Blouin, Sebastien Jacquelin, Pierre Milpied, Felipe Suarez, Richard Delarue, Agnès Buzyn, Bruno Varet, Wolf H Fridman, Véronique Fremeaux-Bacchi, Olivier Hermine

Blood (2009) 114 (22): 1166.

https://doi.org/10.1182/blood.V114.22.1166.1166

Published: 2009

Journal Articles

Complement System Activation after Allogeneic Bone Marrow Transplantation May Early Predict the Development of Acute Gastrointestinal GVHD.

Marie T. Rubio, MD, PhD, Marie A. Dragon-Durey, MD, PhD, Sébastien Jacquelin, Jacques Blouin, Natacha Maillard, MD, David Ghez, MD, Felipe Suarez, MD, Richard Delarue, MD, Agnès Buzyn, MD, PhD, Bruno Varet, MD, Wolf H. Fridman, MD, PhD, Véronique Frémeaux-Bacchi, MD, PhD, Olivier Hermine, MD, PhD

Blood (2007) 110 (11): 2186.

https://doi.org/10.1182/blood.V110.11.2186.2186

Published: 2007

Journal Articles

Results of the AFR07 Prospective Study in De Novo Philadelphia Positive ALL Patients Aged over 55 Years: Efficacy and Safety of a Glivec® Based Induction Followed by Maintenance Therapy with Glivec® and Pegasys®.

Philippe Rousselot, Christian Recher, Agnès Buzyn, Francis Witz, Norbert Vey, Martine Escoffre-Barbe, Olivier Legrand, Pascal Turlure, Françoise Huguet, Thibaut Leguay, Jacques Delaunay, Bruno Audhuy, Cécile Fohrer, Sébastien Maury, Sylvie Castaigne, Eric Vicaux, Hervé Dombret, Jean Michel Cayuela

Blood (2007) 110 (11): 2816.

https://doi.org/10.1182/blood.V110.11.2816.2816

Published: 2007

Journal Articles

Outcome of Patients with T-Cell Lymphoblastic Leukemia or Lymphoma: The GRAALL Experience.

Stéphane Leprètre, Martine Escoffre-Barbe, Patrice Chevallier, Thibaut Leguay, Laurence Legros, Emmanuel Raffoux, Philippe Rousselot, Pascal Turlure, Norbert Vey, Denis Guyotat, Yves Chalandon, André Delannoy, Marie-Christine Béné, Elizabeth Macintyre, Norbert Ifrah, Françoise Huguet, Hervé Dombret, Agnès Buzyn

Blood (2007) 110 (11): 2818.

https://doi.org/10.1182/blood.V110.11.2818.2818

Published: 2007

Journal Articles

Prognostic Significance of CD20 Expression in Adult B-Cell Precursor Acute Lymphoblastic Leukemia.

Blood (2007) 110 (11): 2829.

https://doi.org/10.1182/blood.V110.11.2829.2829

Published: 2007

Journal Articles

Fludarabine Plus Cyclophosphamide and Rituximab (RFC) in Waldenström’s Macroglobulinemia (WM): Results in 21 Patients (pts).

Jacques Vargaftig, MD, Brigitte Pegourié-Bandelier, MD, Béatrice Mahé, MD, Steven Le Gouill, MD, PhD, Elisabeth Brottier-Mancini, MD, Richard Delarue, MD, Agnès Buzyn, MD, PhD, Martine Raphael, MD, Sylvain Choquet, MD, Véronique Leblond, MD

Blood (2006) 108 (11): 4727.

https://doi.org/10.1182/blood.V108.11.4727.4727

Published: 2006

Journal Articles

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study

Blood (2006) 109 (4): 1408–1413.

https://doi.org/10.1182/blood-2006-03-011908

Published: 2006

Includes: Supplemental data

Journal Articles

Atypical BCR-ABL Transcripts Chronic Myelogenous Leukemias Show Particular Features, and Their Classical Worse Prognosis Seems Abrogated by Imatinib Mesylate. A Retrospective Analysis of 22 Patients, on the Behalf of the French Intergroup of CML (Fi(ϕ)-LMC Group).

Franck E. Nicolini, MD, PhD, Nathalie Grardel, MD, Sandrine Hayette, PhD, Jean-Michel Cayuela, MD, Agnès Buzyn, MD, PhD, Eric Delabesse, MD, Christian Bastard, MD, Odile Blanchet, MD, Nathalie Sorel, PhD, Marie-Josée Mozziconacci, MD, Ali Turhan, MD, PhD, Virginie Eclache, MD, François-Xavier Mahon, MD, PhD, Nicole Dastugue, MD, Eric Legac, MD, Marie-Pierre Gaub, MD, Sélim Corm, MD, Claude Preudhomme, MD, PhD

Blood (2005) 106 (11): 3285.

https://doi.org/10.1182/blood.V106.11.3285.3285

Published: 2005

Journal Articles

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly with Imatinib Mesylate (STI571) and Chemotherapy.

Blood (2005) 106 (11): 146.

https://doi.org/10.1182/blood.V106.11.146.146

Published: 2005

Journal Articles

Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase

Martine Gardembas, Philippe Rousselot, Michel Tulliez, Magda Vigier, Agnès Buzyn, Françoise Rigal-Huguet, Laurence Legros, Mauricette Michallet, Christian Berthou, Nathalie Cheron, Frederic Maloisel, François-Xavier Mahon, Thierry Facon, Patrice Berthaud, Joëlle Guilhot, François Guilhot, for the CML French Group (FIϕLMC)

Blood (2003) 102 (13): 4298–4305.

https://doi.org/10.1182/blood-2003-04-1010

Published: 2003

Journal Articles

CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRγδ lineage

Vahid Asnafi, Isabelle Radford-Weiss, Nicole Dastugue, Chantal Bayle, Daniel Leboeuf, Christiane Charrin, Richard Garand, Marina Lafage-Pochitaloff, Eric Delabesse, Agnès Buzyn, Xavier Troussard, Elizabeth Macintyre

Blood (2003) 102 (3): 1000–1006.

https://doi.org/10.1182/blood-2002-09-2913

Published: 2003

Journal Articles

Analysis of TCR, pTα, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment

Vahid Asnafi, Kheira Beldjord, Emmanuelle Boulanger, Béatrice Comba, Patricia Le Tutour, Marie-Hélène Estienne, Frédéric Davi, Judith Landman-Parker, Pierre Quartier, Agnès Buzyn, Eric Delabesse, Françoise Valensi, Elizabeth Macintyre

Blood (2003) 101 (7): 2693–2703.

https://doi.org/10.1182/blood-2002-08-2438

Published: 2003

NARROW

Towards a Purely Oncogenetic Risk Classification of Adult T-ALL: a GRAALL Study

Minimal Residual Disease At 3 Months, Combined to the Presence of IKZF1 Deletion in B-Lineage or Absence of NOTCH1 pathway Mutation in T-Lineage, Recapitulates the Disease Risk Assessment in Adults with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia - A GRAALL Study

Clinical Phenotype and Response to Imatinib of Chronic Myelogenous Leukemia Patients Harbouring Atypical BCR-ABL Transcripts. A Retrospective Analysis From the French Group of CML (Fi-LMC) and the French Group of Molecular Biologists for Hematological Malignancies (GBMHM).

Fludarabine Plus Cyclophosphamide and Rituximab In Waldenström's Macroglobulinemia: Results In 55 Patients

Is There Still a Place for Total Body Irradiation (TBI) In the Conditioning Regimen of Autologous Stem Cell Transplantation In Mantle Cell Lymphoma ?: a Retrospective Study From the Lymphoma Working Party of the EBMT

Allogeneic Stem Cell Transplantation (allo-SCT) for Isolated and Leukemic Myeloid Sarcoma (GS): a Survey on Behalf of the Acute Leukemia Working Party (ALWP) of EBMT.

Improved Survival for 149 First-Line Multiple Myeloma (MM) Patients (pts) Treated by Tandem Autologous (Auto)/Allogeneic (Allo) Stem Cell Transplantation (SCT) : Retrospective Study of the Société Française de Greffe de Moelle Thérapie Cellulaire (SFGM-TC).

Impact of Donor-Derived Invariant Natural Killer T (iNKT) Cell Reconstitution After Allogeneic Haematopoietic Stem Cell Transplantation.

Prognostic Significance of Complement System Activation After Allogeneic Hematopoietic Stem Cell Transplantation.

Complement System Activation after Allogeneic Bone Marrow Transplantation May Early Predict the Development of Acute Gastrointestinal GVHD.

Results of the AFR07 Prospective Study in De Novo Philadelphia Positive ALL Patients Aged over 55 Years: Efficacy and Safety of a Glivec® Based Induction Followed by Maintenance Therapy with Glivec® and Pegasys®.

Outcome of Patients with T-Cell Lymphoblastic Leukemia or Lymphoma: The GRAALL Experience.

Prognostic Significance of CD20 Expression in Adult B-Cell Precursor Acute Lymphoblastic Leukemia.

Fludarabine Plus Cyclophosphamide and Rituximab (RFC) in Waldenström’s Macroglobulinemia (WM): Results in 21 Patients (pts).

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study

Atypical BCR-ABL Transcripts Chronic Myelogenous Leukemias Show Particular Features, and Their Classical Worse Prognosis Seems Abrogated by Imatinib Mesylate. A Retrospective Analysis of 22 Patients, on the Behalf of the French Intergroup of CML (Fi(ϕ)-LMC Group).

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly with Imatinib Mesylate (STI571) and Chemotherapy.

Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase

CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRγδ lineage

Analysis of TCR, pTα, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only